Sean co-founded Omada in 2011 with the aim of merging medical trends and cutting edge technology to revolutionize health care of chronic disease as we know it. Today, he proudly serves as CEO and has been instrumental in steering Omada toward global recognition, such as being hailed a potential “medical triumph” by The New York Times, and one of Fast Company’s 50 most innovative companies in the world.
A longtime devotee of healthcare and technology, Sean also founded a largely automated lifestyle business around Excel Everest, the interactive Microsoft Excel training tool he created. He formerly covered healthcare innovation as writer and editor for Medgadget, a popular medical technology blog.
As CEO of Omada, Sean cares deeply about honing the organization’s exceptional products, values-driven approach to healthcare, and the innovative ways in which primary care can continue to better humanity.
More recently, Sean has been spending more and more of his free time learning how to build and fly first-person view drones.
Adrian co-founded Omada in 2011 in the hopes of improving public health outcomes through human-centered design. A key member of the executive team and the board of directors, he focuses on bolstering the quality of Omada’s integrated care programs and enhancing member experience.
He also serves as a healthtech advisor for the venture capital and private equity firm Necessary Ventures, and sits on the board of Moving Analytics, Inc., a healthtech company focused on digital prevention and care of heart disease. Prior to co-founding Omada, Adrian led the medical products division of IDEO’s Health Practice, where he focused on business development and client relationships. He holds a Bachelor of Science degree and Master of Science degree in Mechanical Engineering from Stanford University.
Adrian believes wholeheartedly in helping create leadership and entrepreneurial opportunities for historically underrepresented and underserved demographics. He volunteers with the African Diaspora Network as a business mentor the inaugural cohort of the Accelerating Black Leadership & Entrepreneurship (ABLE) program.
Wei-Li is a global executive and leader with over 20 years of experience building and leading biopharmaceutical and diagnostic imaging businesses in the United States, New Zealand, China, and Taiwan. He came to Omada in 2019 following a rewarding 18-year career as an executive at global pharmaceutical company Eli Lilly and Company.
Wei-Li holds dual Bachelor of Science degrees in biochemistry and molecular biology from the University of Wisconsin-Madison and a Master of Business Administration from the Kelley School of Business, Indiana University.
As Omada’s President, Wei-Li is passionate about the organization’s strong foundations rooted in patient-centered technology, medical-grade evidence, and a scaled business model. His guidance and expertise has helped guide Omada’s expanded product offerings, integration with key partners, leveraging of new business channels, and overall strategic vision. Wei-Li hopes to continue redefining what digital healthcare can be, and should do.
Wei-Li is also a children’s book author having published Anny The Tall Girl, a story of diversity, equity, and inclusion. He and his wife Sarah are the proud parents of two daughters.
Steve has well over a decade of high-level experience working with reputable technology companies in financial strategy. Since joining Omada as its CFO in the summer of 2021, he has been an integral part of executive leadership.
Steve graduated from the University of California, San Diego with a Bachelor of Arts degree in Political Science. He previously worked as Salesforce’s Senior Manager of Finance & Strategy, and One Medical’s Vice President and Head of Strategic Finance.
As CFO, Steve oversees operational activities and guides strategic financial planning and direction to facilitate company growth. He is passionate about furthering Omada’s commitment to deliver personalized, cost-effective digital care to people at-risk and living with chronic conditions.
William has over 20 years of experience protecting and overseeing information security, information technology (IT) operations, and managed services for a host of technology companies. A self-proclaimed “tech geek,” he helped lead Omada through its hyper-growth phase by shaping all aspects of internal IT, end-user support, vendor management, operational security and compliance.
He holds a Bachelor of Science degree in business administration and management from Pepperdine University, and a Master of Science degree in IT security from Capella University. In 2020, William was named a Pepperdine University Outstanding Alumni in Healthcare Honoree. Before coming to Omada, William was RagingWire Data Center’s Senior Vice President and Chief Technology Officer, and StubHub’s Director of Site Operations.
In 2017, William led efforts to make Omada the first digital therapeutics company to achieve both a HITRUST and SOC 2 certification for their services. With healthcare being one of the most breached industries, William takes great pride in helping prevent security lapses from creating a barrier to people receiving the best care possible. His IT and security contributions to Omada’s operations are an integral part of the company’s ability to live up to its mission and values.
William is also an avid nature photographer who captures the essence of Napa Valley’s landmarks and landscapes.
Carolyn is a board-Certified physician with a career spanning health technology startups, multidisciplinary care, education, and research associateships. As Omada’s Chief Medical Officer, she leverages her versatile skill set to benefit user experience and introduce patients and providers to integrated healthcare solutions.
Before joining Omada, Carolyn spent 14 years with the University of California as an Associate Professor of Pediatrics and Clinical Instructor at San Francisco General Hospital. She’s also the former Vice President of medical outcomes for Mango Health, a digital health startup. She completed her Bachelor’s Degree in public policy from Princeton University’s Woodrow Wilson School, her Medical Degree at the University of Chicago’s Pritzker School of Medicine, and her research training at the University of California, San Francisco. Carolyn is board-certified in clinical informatics, adolescent medicine, and pediatrics.
At Omada, Carolyn supports the clinical and research teams to create and test the next generation of integrated chronic disease care programming via digital therapeutics. Her work comprises an invaluable component of Omada’s stellar user experience benefiting patients and providers alike.
Sunil is a proven technology innovator and strategic business advocate with well over two decades of progressive leadership experience. He specializes in a variety of disciplines, including cloud and software engineering, product development, information technology infrastructure design, technology operations, mobile application development, and global team management.
Throughout his career, he has been motivated by a passion for developing innovative solutions to complex challenges and streamlining operations and business processes to benefit organizations he has worked for, including Fidelity Investments, Eze Software, Chrome River Technologies and Emburse.
As Omada’s Chief Technology Officer, Sunil brings a healthy enthusiasm to his efforts leading a team of highly capable technologists. Under his strategic leadership, Omada’s technology growth and developments are helping drive healthcare modernization and scalable improvements that translate into measurable outcomes for our partners.
Sunil completed his undergraduate studies in computer engineering at Mangalore University in India. He then went on to earn his Master of Science in computer science at the University of South Carolina and a Master of Business Administration from the University of Massachusetts.
In his spare time, you will find Sunil enjoying the outdoors, hiking, biking, boating and during winters snowmobiling in the New Hampshire wilderness.
Lucia has over two decades of experience in healthcare across the private, non-profit, and governmental sectors. As Omada’s Chief Privacy & Regulatory Officer, she leads the organization’s regulatory strategy and seamless integration of operations into clinical processes.
A graduate of New York University’s School of Law, Lucia is an experienced C-suite executive and board member. She advises CEOs, Cabinet Secretaries, and elected officials on the optimization of digital healthcare in the 21st Century.
Prior to joining Omada, she served as Chief Privacy Officer at the Office of the National Coordinator for Health IT (ONC). There, she advised the National Coordinator for Health IT and other federal partners about how to ensure privacy and security of health information. Lucia also previously served as the Senior Associate General Counsel at United Healthcare, working with large data transactions related to health information exchanges, healthcare transparency projects, academic research, and other data-driven healthcare innovation projects.
Her storied career and tireless efforts to empower people in search of better healthcare outcomes was recognized by SC Magazine, which named her "one of the largest patient privacy and digital health advocates" in the nation.
Nate is Omada’s motivated and talented in-house counsel whose expertise spans a wide range of legal issues. As Omada’s well-respected general counsel, he works closely with company leadership to provide pragmatic, value-driven legal advice in support of the organization’s broader mission––delivering meaningful health outcomes for members.
A graduate of the University of California, Berkeley, School of Law, Nate was previously an Associate at Latham & Watkins LLP, one of the world’s largest multinational law firms. There, he focused on general corporate law, securities law and transactional matters, with an emphasis on internet and technology companies, life sciences companies, venture capital transactions and capital markets.
In his spare time, Nate loves to seek out new culinary experiences by visiting the latest restaurants in San Francisco and trying out elaborate recipes and techniques for his friends and family.
As a trusted Chief People Officer of mission-driven companies, Nancy has led transformation, business growth, and profitability through people, strategy and culture for leading organizations, including Genentech/Roche, Procter & Gamble, CIGNA, and Deloitte Consulting. With over 25 years of experience, she’s also an award-winning human resources thought leader, known for building great places to work.
As Omada’s Chief People Officer, Nancy leverages her vast industry experience to provide strategic leadership that addresses a wide spectrum of employee and organizational needs. Her expertise drives solutions that help Omada’s team members do their best work and achieve the lofty goals we set for ourselves.
Nancy is a Board Director for a prominent life sciences company and previously for a well known nonprofit. She’s also a Senior Faculty Member of The Josh Bersin Academy, a global development academy for human resources and talent professionals supporting organizations worldwide.
Nancy earned her Bachelor of Business Administration at the University of Michigan’s Stephen M. Ross School of Business. She then completed her graduate studies at Emory University’s Goizueta Business School, achieving a Master of Business Administration.
Nancy enjoys 5k runs with her wife and son, hanging out with friends and exploring new places with her family, whether it's a new local restaurant or a new country.
Randhir is a talented executive and leading business mind with over 25 years of experience in product management, marketing, sales, business development and human resources at both start-ups and large corporations.
Highly accomplished, he has been lauded for his successful business strategies and implementation with companies such as Headspace Inc., where he served as VP of Products, and Yahoo, where he spent time as the Senior Director of Product Management. His professional experiences also include designing, building, and driving the adoption of carefully crafted business solutions, including conveying complex concepts and solutions to technical and non-technical audiences.
As Omada’s SVP of Product Management, Randhir helps define the strategic direction and leads the product roadmap for the core areas of Omada’s multi-condition virtual care pathways. Sitting at the heart of the customer, business and technology, he oversees and drives a product vision that translates into a valuable consumer experience.
Randhir completed his undergraduate studies at St. Xavier’s College in Mumbai, India. He then went on to earn a Master of Arts degree in Personnel Management from the Tata Institute of Social Sciences, also in Mumbai. Finally, he achieved his Master of Business Administration in Marketing from Emory University in Atlanta.
He enjoys traveling, hiking and trying to cook new dishes. He and his wife Beata live in the San Francisco Bay area and have a daughter and son.
Chris is an operator at heart with over 15 years of experience applying systems thinking and data driven decision making to support organizations across the private, non-profit, and governmental sectors in solving their most challenging problems. Passionate about what can be achieved at the intersection of technology and human services, Chris has spent the last 10 years focused on leveraging innovative, tech driven solutions to effectively scale human care.
Chris holds a Bachelor of Science degree in Mathematics from Samford University and an M.Phil. in Policy Analysis from the Pardee RAND Graduate School with a focus in Applied Economics and Quantitative Methods. Prior to joining Omada, Chris served as Vice President, Knowledge Management and Planning at Single Stop, a national non-profit committed to addressing systemic poverty by providing coordinated access to community resources and public benefits. He also previously worked as a Doctoral Fellow and analyst at the RAND Corporation.
As Omada’s SVP, Operations & Care Delivery, Chris applies his passion and energy to designing and operationalizing new models for effective, scaled delivery of care across Omada’s digital health programs. He is grateful to have the opportunity to support and lead an incredible group of Omadans across our Health Coaching, Clinical Operations, Member Operations & Device Strategy, and Supply Chain teams.
Chris and his wife Debbie are the proud parents of two incredible daughters, and they spend most of their free time chasing opportunities to introduce their kids to the wonders of the outdoors. Whenever possible, that includes finding a mountain stream with a fly rod in hand.
We created this company to inspire and engage people in lifelong health one step at a time.
CEO & Co-Founder, Omada Health
Board of Directors
Meet the Omada Board of Directors, a team whose varied backgrounds unite the disciplines of technology, life sciences, and health care delivery.
Jeryl Hilleman, an experienced corporate director, currently serves as the Chairperson of the Board for Omada Health. She's served on public and private company Boards of Directors for nearly two decades, presently including Novocure (NVCR), SI-Bone (SIBN), HilleVax. (HLVX), Minerva Neurosciences (NERV) and the Reiter Affiliated Companies, the international farming arm of Driscoll's Berries. Ms. Hilleman also serves on diverse Board committees including the Audit (as Chair), Nominating and Corporate Governance, Compensation, Risk, Pricing, and M&A Committees.
Previously, Ms. Hilleman served as CFO of several global public companies in the life sciences sector where she was responsible for raising over one billion dollars in equity and debt financings as well as completing five successful IPOs and several M&A transactions. Ms. Hilleman graduated from Brown University and earned an MBA from the Wharton School. She is a member of the 1999 class of the Henry Crown Fellows and the Aspen Global Leadership Network at the Aspen Institute.
Casper de Clercq holds over 30 years of experience in the medical device and life sciences industry. As a General Partner at Norwest Venture Partners, he brings extensive operating knowledge and focuses on mid-to-late-stage investments in consumer and digital health, healthcare IT, medical devices and diagnostics, technology-enabled healthcare services, and specialty pharmaceuticals. He currently serves on the boards of Clever Care Health Plan, NextHealth Technologies, Omada Health, Robin Healthcare, Monogram Health, and Science Exchange. Casper is also responsible for Norwest’s investment in BillionToOne and Misfit Wearables (acquired by Fossil).
Prior to Norwest, Casper was a Partner at U.S. Venture Partners and the Vice President of Business Development, Sales, and Marketing at Aerogen. In 1999, he co-founded and venture funded Epicor (acquired by St. Jude Medical for over $200M). Casper has also held senior marketing positions at Heartport (acquired by Johnson & Johnson) and Diagnostic Products Corporation (acquired by Siemens).
Casper holds an M.B.A. from Stanford University Graduate School of Business, an M.S. in biological science from Stanford University, and a B.A. in biochemistry from Dartmouth College.
Dr. Jennifer Gutzmore brings years of medical practice and healthcare experience as an officer on Omada Health's Board of Directors. Gutzmore joined Cigna in 2009 as a Regional Medical Executive of the West region and currently serves as a Medical Officer in clinical quality and performance. Passionate about the transformation of healthcare delivery, she co-leads a market-facing clinical team of physicians and nurses that supports the execution of Cigna's strategic and business objectives. Gutzmore's team ensures improved affordability, predictability, and enhanced healthcare outcomes while delivering a market-differentiated customer and provider experience in close collaboration with provider partners, clients, care coordination, and medical management organizations. In addition, she sits on the National Clinical Performance Committee for NCQA.
Before joining Cigna, she practiced internal medicine and geriatrics, served as Chief Medical Director for Medicare at Anthem, Chief Medical Officer for Health Net of California, and Chief Medical Officer of Talbert Medical Group MSO.
Dr. Gutzmore received her medical degree from George Washington University School of Medicine and her undergraduate degree from Brandeis University. She completed a residency at Henry Ford Hospital and is currently board certified in internal medicine.
Jonathan Root, M.D. has served as a member of Omada’s Board since 2013.
Dr. Root has served as a Managing Member of Presidio Management Group, LLC and several U.S. Venture Partners’ funds, which are the general partners of various other venture capital funds, since 1998. Dr. Root currently serves on the board of directors of Edgewise Therapeutics (NASDAQ: EWTX), Inari Medical (NASDAQ: NARI), Silverback Therapeutics, Inc. (NASDAQ: SBTX) and several private companies in the healthcare industry. Dr. Root joined U.S. Venture Partners as a Ewing Marion Kauffman Fellow in venture capital in 1995.
Before USVP, Dr. Root was an Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Special Care Unit at The New York Hospital - Cornell Medical Center. Dr. Root serves on the Investment Advisory Committee of Mission Bay Capital and the Dartmouth Innovations Accelerator for Cancer External Review Panel. Dr. Root is a former board member of the National Venture Capital Association.
Dr. Root received an A.B. from Dartmouth College, an M.D. from University of Florida, College of Medicine and an M.B.A. from Columbia Business School.
Taylor Harris currently sits on the Omada Health Board of Directors and most recently served as the Chief Financial Officer of MyoKardia, Inc., a clinical-stage biopharmaceutical company that was acquired in November 2020 by Bristol Myers Squibb. Before joining MyoKardia, Mr. Harris served as Chief Financial Officer of Zeltiq Aesthetics, Inc., until that company's acquisition by Allergan. Prior to Zeltiq, he was Thoratec Corporation's Chief Financial Officer until that company was acquired by St. Jude Medical, Inc. Mr. Harris began his career at JPMorgan Chase & Co., where he worked for over a decade as a Vice President in the firm's Healthcare Investment Banking and Equity Research departments
Mr. Harris holds a Bachelor of Arts in Physics and Economics from the University of North Carolina at Chapel Hill, where he studied as a Morehead-Cain Scholar.
Trevor Fetter is a Senior Lecturer on the faculty of Harvard Business School, where he teaches two required MBA courses.
Before joining the faculty, he was Chairman and Chief Executive Officer of Tenet Healthcare Corp. Under his leadership, the company grew to $20 billion in revenues (Fortune ~#130) and employed 130,000 people. Tenet was one of the ~50 largest employers in the U.S. and had operations in more than 40 states and the United Kingdom.
In addition to teaching, Trevor is an active corporate director, advisor and investor. He currently serves as lead independent director of The Hartford Financial Services Group and serves on the boards of and is an investor in private healthcare services and healthcare technology companies Omada Health, Trimedx Inc., and Regent Surgical Health. He is also a director of the Santa Catalina Island Company. Trevor serves on the board of the Catalina Island Conservancy, the Board of Fellows of Stanford Medicine, and the Smithsonian National Board. At Harvard Business School, he has served on the board of dean’s advisors and the healthcare initiative advisory board.
Trevor received a bachelor’s degree in economics from Stanford University in 1982 and an MBA from Harvard Business School in 1986. He is married to his Stanford classmate, Melissa Fetter, a community volunteer and proprietor of Beacon Hill Books and Café in Boston. Together they were honored with the 2017 Henry Cohn Humanitarian Award presented by the Anti-Defamation League.
Vijay Pande, PhD, is a general partner at Andreessen Horowitz, where he focuses on investments in biopharma and healthcare. Pande serves on the boards of Apeel Sciences, BioAge, Devoted Health, Freenome, Insitro, Nobell, Omada Health, Q.bio, and Scribe Therapeutics. Pande is also an Adjunct Professor of Bioengineering at Stanford University, where he continues to advise the Pande Lab, with a focus on tackling challenging problems in chemical biology, biophysics, and biomedicine.
As the founding investor of a16z's Bio Fund, Pande leads the firm's investments at the cross-section of biology and computer science. Areas of focus include applications in computation, machine learning, and artificial intelligence in healthcare, digital therapeutics, diagnostics, and other novel transformative scientific advances applied to an industry that takes bio beyond healthcare.
Previously, Pande was the Henry Dreyfus Professor of Chemistry and Professor of Structural Biology and of Computer Science at Stanford University, where he led a team of researchers pioneering computational methods and their application to medicine and biology (resulting in over 300 publications, two patents, and two novel drug candidates). Pande was also concurrently the Director of the Biophysics program at Stanford, where he led a team of more than 50 faculty members and propelled the program to one of the top in the country.
During his time at Stanford, Pande co-founded Globavir Biosciences, where he translated his research advances into a successful startup that aimed to discover cures for Dengue Fever and Ebola. Pande also founded the Folding@Home Distributed Computing Project for disease research, which pushed the boundaries of computer science techniques (distributed systems, machine learning, and exotic computer architectures) into biology and medicine, in both research as well as the development of new therapeutics.
Pande holds a BA in Physics from Princeton University and a PhD in Physics from MIT. He has been awarded the DeLano Prize in Computation; a Guinness World Record for Folding@Home; the American Chemical Society Thomas Kuhn Paradigm Shift Award; and was selected for MIT TR10. In his teens, Vijay was the first employee at video game startup Naughty Dog Software, the maker of Crash Bandicoot.